
Market capitalization change in key COVID-19 firms until end-May 2020
Gilead Sciences' market capitalization had increased by 26.3 billion U.S. dollars up to May 27, 2020. Gilead Sciences shot to the public spotlight due to trials of its drug remdesivir which is seen as a possible treatment for COVID-19.